NL
Numerion Labs, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$19.8Msold at filing
Total offering$35M$15.2M still open
Investors in the raise5count reported to the SEC
FiledMar 19, 2026first sale Mar 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Stephen WorlandExecutive Officer, Director
Adam SeabrookDirector
Izhar WallachDirector
Yan ZhaoExecutive Officer
Mike VarneyDirector
Robert MittendorffDirector
Linda MaxwellDirector
Executive officers, directors and promoters as listed on the Form D.